RVL Pharmaceuticals plc (RVLPQ)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 9, 2026
RVL Pharmaceuticals Market Cap
RVL Pharmaceuticals has a market cap or net worth of $111 as of October 9, 2026. It is the 52,854th most valuable company in the world and the 8,879th biggest in the United States.
Market Cap
111.00
Enterprise Value
n/a
Revenue
36.92M
Global Rank
Country Rank
#8,879 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since October 18, 2018, RVL Pharmaceuticals's market cap has decreased from 419.90M to 111.00, a decrease of -100.00%. That is a compound annual growth rate of -85.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 111.00 | - |
| Dec 31, 2025 | 111.00 | - |
| Dec 31, 2024 | 111.00 | -99.97% |
| Dec 29, 2023 | 334.22K | -99.70% |
| Dec 30, 2022 | 111.05M | 23.46% |
| Dec 31, 2021 | 89.95M | -65.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kiromic BioPharma | 157.00 |
| Regenicin | 153.00 |
| Poniard Pharmaceuticals | 150.00 |
| NexImmune | 139.00 |
| Seelos Therapeutics | 136.00 |
| PsyBio Therapeutics | 133.00 |
| Marizyme | 132.00 |
| HEALTHeUNIVERSE | 118.00 |